California State Teachers Retirement System Ligand Pharmaceuticals Inc Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 16,927 shares of LGND stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,927
Previous 16,430 3.02%
Holding current value
$1.89 Million
Previous $1.38 Million 22.47%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$82.7 - $110.11 $41,101 - $54,724
497 Added 3.02%
16,927 $1.7 Million
Q2 2024

Aug 14, 2024
SELL
$68.53 - $87.91 $11,238 - $14,417
-164 Reduced 0.99%
16,430 $1.38 Million
Q1 2024

May 15, 2024
SELL
$68.64 - $89.2 $63,217 - $82,153
-921 Reduced 5.26%
16,594 $1.21 Million
Q4 2023

Feb 13, 2024
SELL
$49.57 - $72.63 $33,311 - $48,807
-672 Reduced 3.69%
17,515 $1.25 Million
Q3 2023

Nov 14, 2023
SELL
$58.86 - $72.67 $96,177 - $118,742
-1,634 Reduced 8.24%
18,187 $1.09 Million
Q2 2023

Aug 21, 2023
SELL
$69.53 - $79.33 $44,638 - $50,929
-642 Reduced 3.14%
19,821 $1.43 Million
Q1 2023

May 09, 2023
SELL
$65.67 - $77.08 $17,336 - $20,349
-264 Reduced 1.27%
20,463 $1.51 Million
Q4 2022

Feb 14, 2023
BUY
$61.72 - $96.74 $15,183 - $23,798
246 Added 1.2%
20,727 $1.38 Million
Q3 2022

Nov 18, 2022
SELL
$0.01 - $107.56 $2 - $28,826
-268 Reduced 1.29%
20,481 $1.76 Million
Q2 2022

Aug 15, 2022
BUY
$74.52 - $117.06 $10,805 - $16,973
145 Added 0.7%
20,749 $1.85 Million
Q1 2022

May 16, 2022
SELL
$94.99 - $151.56 $161,577 - $257,803
-1,701 Reduced 7.63%
20,604 $2.32 Million
Q4 2021

Feb 15, 2022
BUY
$127.69 - $165.85 $64,994 - $84,417
509 Added 2.34%
22,305 $3.45 Million
Q3 2021

Nov 15, 2021
BUY
$102.33 - $144.73 $102,636 - $145,164
1,003 Added 4.82%
21,796 $3.04 Million
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $108,621 - $149,570
-961 Reduced 4.42%
20,793 $2.73 Million
Q1 2021

May 18, 2021
SELL
$99.52 - $215.83 $11,146 - $24,172
-112 Reduced 0.51%
21,754 $3.32 Million
Q4 2020

Feb 16, 2021
BUY
$80.55 - $106.05 $7,652 - $10,074
95 Added 0.44%
21,866 $2.18 Million
Q3 2020

Nov 17, 2020
BUY
$89.56 - $126.72 $1,791 - $2,534
20 Added 0.09%
21,771 $2.08 Million
Q2 2020

Aug 17, 2020
SELL
$68.28 - $123.65 $291,350 - $527,614
-4,267 Reduced 16.4%
21,751 $2.43 Million
Q1 2020

May 13, 2020
SELL
$63.37 - $107.88 $8,174 - $13,916
-129 Reduced 0.49%
26,018 $1.89 Million
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $264,452 - $309,873
-2,728 Reduced 9.45%
26,147 $2.73 Million
Q3 2019

Nov 15, 2019
SELL
$86.25 - $120.16 $46,143 - $64,285
-535 Reduced 1.82%
28,875 $2.87 Million
Q2 2019

Aug 14, 2019
SELL
$107.38 - $129.34 $281,442 - $339,000
-2,621 Reduced 8.18%
29,410 $3.36 Million
Q1 2019

May 09, 2019
SELL
$105.93 - $142.47 $75,528 - $101,581
-713 Reduced 2.18%
32,031 $4.03 Million
Q4 2018

Feb 13, 2019
BUY
$128.36 - $272.13 $94,858 - $201,104
739 Added 2.31%
32,744 $4.44 Million
Q3 2018

Nov 14, 2018
SELL
$211.18 - $274.49 $2,534 - $3,293
-12 Reduced 0.04%
32,005 $8.79 Million
Q2 2018

Aug 14, 2018
BUY
$150.77 - $207.98 $120,314 - $165,968
798 Added 2.56%
32,017 $6.63 Million
Q1 2018

May 15, 2018
SELL
$138.63 - $182.62 $151,799 - $199,968
-1,095 Reduced 3.39%
31,219 $5.16 Million
Q4 2017

Feb 14, 2018
SELL
$128.36 - $147.04 $61,741 - $70,726
-481 Reduced 1.47%
32,314 $4.43 Million
Q3 2017

Nov 13, 2017
BUY
$120.91 - $137.94 $3.97 Million - $4.52 Million
32,795
32,795 $4.47 Million

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email